These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 27431460)
1. Management and Outcomes in Metaplastic Breast Cancer. Tzanninis IG; Kotteas EA; Ntanasis-Stathopoulos I; Kontogianni P; Fotopoulos G Clin Breast Cancer; 2016 Dec; 16(6):437-443. PubMed ID: 27431460 [TBL] [Abstract][Full Text] [Related]
2. Prolonged survival of patients with breast cancer-related leptomeningeal metastases. Le Rhun E; Taillibert S; Zairi F; Pannier D; Boulanger T; Andre C; Cazin JL; Dubois F; Bonneterre J; Chamberlain MC Anticancer Res; 2013 May; 33(5):2057-63. PubMed ID: 23645756 [TBL] [Abstract][Full Text] [Related]
3. [Does obesity modify recurrence-free interval in breast cancer?]. Kurz C; Obermair A; Schemper W; Kubista E; Sevelda P Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():305-7. PubMed ID: 8118326 [No Abstract] [Full Text] [Related]
4. Metaplastic carcinoma of the breast. Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684 [TBL] [Abstract][Full Text] [Related]
5. Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma. Chang JM; McCullough AE; Dueck AC; Kosiorek HE; Ocal IT; Lidner TK; Gray RJ; Wasif N; Northfelt DW; Anderson KS; Pockaj BA Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S509-15. PubMed ID: 26001860 [TBL] [Abstract][Full Text] [Related]
6. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran. Amirifard N; Sadeghi E Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636 [TBL] [Abstract][Full Text] [Related]
7. Management of in situ carcinoma of the breast: lobular and ductal origin. White RE; Bland KI R I Med; 1995 Sep; 78(9):242-5. PubMed ID: 7579718 [No Abstract] [Full Text] [Related]
8. Aurora kinase A as a possible marker for endocrine resistance in early estrogen receptor positive breast cancer. Lykkesfeldt AE; Iversen BR; Jensen MB; Ejlertsen B; Giobbie-Hurder A; Reiter BE; Kirkegaard T; Rasmussen BB Acta Oncol; 2018 Jan; 57(1):67-73. PubMed ID: 29202611 [TBL] [Abstract][Full Text] [Related]
9. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case-control study of 87 cases. Genin AS; De Rycke Y; Stevens D; Donnadieu A; Langer A; Rouzier R; Lerebours F Breast; 2016 Dec; 30():222-227. PubMed ID: 26456897 [TBL] [Abstract][Full Text] [Related]
10. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors. Sinha AK; Patel JR; Shen Y; Ueno NT; Giordano SH; Tripathy D; Lopez DS; Barcenas CH PLoS One; 2017; 12(1):e0170081. PubMed ID: 28085940 [TBL] [Abstract][Full Text] [Related]
11. Metaplastic breast carcinoma: Current therapeutic approaches and novel targeted therapies. Drekolias D; Mamounas EP Breast J; 2019 Nov; 25(6):1192-1197. PubMed ID: 31250492 [TBL] [Abstract][Full Text] [Related]
12. Distant metastatic breast cancer as an incurable disease: a tenet with a need for revision. Güth U; Huang DJ; Dirnhofer S; Rochlitz C; Wight E Cancer J; 2009; 15(1):81-6. PubMed ID: 19197181 [TBL] [Abstract][Full Text] [Related]
13. [Observation of an increase in "aggressive tumor forms" in increasing incidence of breast carcinoma]. Engelhardt C; Sauerland C; Bettges G Geburtshilfe Frauenheilkd; 1996 Mar; 56(3):124-7. PubMed ID: 8674957 [TBL] [Abstract][Full Text] [Related]
14. Tumor characteristics and therapy of elderly patients with breast cancer. Grumpelt AM; Ignatov A; Tchaikovski SN; Burger E; Costa SD; Eggemann H J Cancer Res Clin Oncol; 2016 May; 142(5):1109-16. PubMed ID: 26809246 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. Rakha EA; Tan PH; Varga Z; Tse GM; Shaaban AM; Climent F; van Deurzen CH; Purnell D; Dodwell D; Chan T; Ellis IO Br J Cancer; 2015 Jan; 112(2):283-9. PubMed ID: 25422911 [TBL] [Abstract][Full Text] [Related]
16. Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression. Balduzzi A; Bagnardi V; Rotmensz N; Dellapasqua S; Montagna E; Cardillo A; Viale G; Veronesi P; Intra M; Luini A; Pruneri G; Mastropasqua G; Goldhirsch A; Colleoni M Clin Breast Cancer; 2014 Aug; 14(4):258-64. PubMed ID: 24325948 [TBL] [Abstract][Full Text] [Related]
17. Survival of patients with metastatic breast cancer: a single-centre experience. D'hondt R; Spoormans I; Neyens N; Mortier N; Van Aelst F Acta Clin Belg; 2014 Jun; 69(3):194-9. PubMed ID: 24641516 [TBL] [Abstract][Full Text] [Related]
18. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis. Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI Breast J; 2006; 12(1):37-47. PubMed ID: 16409585 [TBL] [Abstract][Full Text] [Related]
19. Breast cancer arising within fibroadenoma: collective analysis of case reports in the literature and hints on treatment policy. Wu YT; Chen ST; Chen CJ; Kuo YL; Tseng LM; Chen DR; Kuo SJ; Lai HW World J Surg Oncol; 2014 Nov; 12():335. PubMed ID: 25382741 [TBL] [Abstract][Full Text] [Related]
20. Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions? Guiu S; Wolfer A; Jacot W; Fumoleau P; Romieu G; Bonnetain F; Fiche M Crit Rev Oncol Hematol; 2014 Dec; 92(3):235-57. PubMed ID: 25129506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]